glp 1 type 1 diabetes Trends in the Development of GLP-1 Receptor Agonists The Ultimate Guide to GLP-1:
Description
doi: 10.1177/0145721710376328
Patients see weight loss, lower blood pressure, better cholesterol numbers, and in many cases, they can cut back on other medications
Miyamoto Y, Banno Y, Yamashita T, Fujimoto T, Oi S, Moritoh Y, et al
The cardiovascular safety and efficacy of tirzepatide in adults with T2D has been assessed in a large phase 3 clinical trial (SURPASS-CVOT) (Table 1) [88]
The NYU study provides the most direct evidence available, and it is reassuring
